Polyrizon logo
Polyrizon
PLRZ | NASDAQ
Chart Builder DCF Calculator
$10.70
-$0.35 (-3.17%)
At close: Nov 16, 2026, 4:00 PM ET
$11.15
+$0.45 (+4.21%)
After-hours: Nov 16, 2026, 7:30 PM ET

Polyrizon Company Profile

Company profile explained

Company Profile

Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.

Key Executives

Name Position
Tomer Izraeli Founder, Chief Executive Officer & Director
Nir Ben Yosef Chief Financial Officer & Compliance Officer
Tidhar Turgeman Chief Technology Officer
Eyal S. Ron Chief Scientific Officer

Latest SEC Filings

Date Type Title
Oct 27, 2026 6-K Filing
Oct 07, 2026 S-8 Filing
Oct 05, 2026 6-K Filing
Oct 01, 2026 EFFECT Filing
Sep 28, 2026 F-1/A [Amend] Filing
Sep 28, 2026 6-K Filing
Sep 18, 2026 F-1 Filing
Sep 10, 2026 D Filing
Sep 04, 2026 6-K Filing
Sep 04, 2026 6-K Filing
View All SEC Filings ➞
Polyrizon
Polyrizon logo
Country Israel
IPO Date Oct 29, 2024
Industry Biotechnology
Sector Healthcare
Employees 6
CEO Tomer Izraeli

Contact Details

5 Ha-Tidhar Street Ra'anana, TA 4321545 Israel

Stock Details

Ticker Symbol PLRZ
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001893645
CUSIP Number M79549206
ISIN Number IL0011814113
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.